Chengdu Kanghua Biological Products Co., Ltd. Stock: price and insider trades · China
康华生物
Chengdu Kanghua Biological Products Co., Ltd.: what insiders have been doing
Chengdu Kanghua Biological Products Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). Chengdu Kanghua Biological Products Co., Ltd. has had no insider filing for more than a year; the last one goes back to 21 November 2023.
The full history, which starts in 2021, counts no purchases against 7 sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 4,600,000 shares100.0% of flowA股XSHESZSE:173000007107661000
- 17,000 shares100.0% of flowA股XSHESZSE:173000006638602720
- 33,900 shares61.6% of flowA股XSHESZSE:173000005476543330
- 58,000 shares100.0% of flowA股XSHESZSE:173000005470545470
- 29,505 shares100.0% of flowA股XSHESZSE:173000005466385600
- 20,000 shares38.4% of flowA股XSHESZSE:173000005464720600
- 425,635 shares100.0% of flowA股XSHESZSE:173000004751923070
7 of 7 declarations
About Chengdu Kanghua Biological Products Co., Ltd.
康华生物 is a company focused on the health and pharmaceutical sector, providing innovative solutions in biotechnology. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
